Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: A meta-analysis and meta-regression

Gene

Volumn 531, Issue 2, 2013, Pages 426-434

  Shen, Wenjing ^a   Li, Tianren ^a   Hu, Yanjie ^a   Liu, Hongbo ^a   Song, Min ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Calpain 10; Meta analysis; Meta regression; Polycystic ovary syndrome; Polymorphism

Indexed keywords

CALPAIN 10;

ACCURACY; ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; CAUCASIAN; COCHRANE LIBRARY; COMPUTER PROGRAM; DNA SEQUENCE; EMBASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CALPAIN-10; CI; CONFIDENCE INTERVAL; HARDY-WEINBERG EQUILIBRIUM; HWE; META-ANALYSIS; META-REGRESSION; ODDS RATIO; OR; PCOS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISMS; SNPS;

ALGORITHMS; ASIAN CONTINENTAL ANCESTRY GROUP; CALPAIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84885424371     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.08.072     Document Type: Article

References (35)

1. Amato P., Simpson J.L. The genetics of polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 2004, 18:707-718.
2. Chen Z.J. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 2011, 43:55-59.
3. Dasgupta S., Reddy B.M. The role of epistasis in the etiology of polycystic ovary syndrome among Indian women: SNP-SNP and SNP-environment interactions. Ann. Hum. Genet. 2013, 77:288-298.
4. Dasgupta S., Sirisha P.V., Neelaveni K., Anuradha K., Reddy B.M. Association of CAPN10 SNPs and haplotypes with polycystic ovary syndrome among South Indian women. PLoS One 2012, 7:e32192.
5. Diao X.H., Shi Y.H., Gao Q., Wang L.C., Tang R., Chen Z.J. Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients. Chin. J. Obstet. Gynecol. 2008, 43:106-109.
6. Ehrmann D.A., et al. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87:1669-1673.
7. Escobar-Morreale H.F., Peral B., Villuendas G., Calvo R.M., Sancho J., San Millan J.L. Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil. Steril. 2002, 77:581-587.
8. Ewens K.G., et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2010, 95:2306-2315.
9. Fauser B.C., et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum. Reprod. 2012, 27:14-24.
10. Franks S., Gharani N., McCarthy M. Candidate genes in polycystic ovary syndrome. Hum. Reprod. Update 2001, 7:405-410.
11. Geisthövel F. A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome. Reprod. Biomed. Online 2003, 7:602-605.
12. Gonzalez A., et al. Comment: CAPN10 alleles are associated with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87:3971-3976.
13. Goodarzi M.O., Dumesic D.A., Chazenbalk G., Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 2011, 7:219-231.
14. Haap M., et al. Genetic determinants of insulin action in polycystic ovary syndrome. Exp. Clin. Endocrinol. Diabetes 2005, 113:275-281.
15. Haddad L., et al. Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87:2606-2610.
16. Huang M., Xiao J., Zhao X., Liu C., Chen Q. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis. Clin. Endocrinol. (Oxf) 2012, 76:431-438.
17. Insenser M., Montes-Nieto R., Murri M., Escobar-Morreale H.F. Proteomic and metabolomic approaches to the study of polycystic ovary syndrome. Mol. Cell. Endocrinol. 2013, 370:65-77.
18. Ioannidis J.P., Patsopoulos N.A., Rothstein H.R. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008, 336:1413-1415.
19. Jackson D., White I.R., Riley R.D. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat. Med. 2012, 31:3805-3820.
20. Lee J.Y., Lee W.J., Hur S.E., Lee C.M., Sung Y.A., Chung H.W. 111/121 diplotype of calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women. Fertil. Steril. 2009, 92:830-833.
21. Li R., Xu L.Z., Xiong D.M. Association between calpain-10 gene polymorphisms and susceptibility to PCOS. J. Sichuan Univ. (Med. Sci. Ed.) 2010, 41:337-339.
22. Marquez J.L., Pacheco A., Valdes P., Salazar L.A. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women. Clin. Chim. Acta 2008, 398:5-9.
23. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295:676-680.
24. Saez M.E., et al. The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population. PLoS One 2008, 3:e2953.
25. Schroder A.K., Tauchert S., Ortmann O., Diedrich K., Weiss J.M. Insulin resistance in patients with polycystic ovary syndrome. Ann. Med. 2004, 36:426-439.
26. Serre D., et al. Correction of population stratification in large multi-ethnic association studies. PLoS One 2008, 3:e1382.
27. Shannon M., Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition. J. Midwifery Womens Health 2012, 57:221-230.
28. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25:603-605.
29. Stroup D.F., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
30. Sun X.Q., et al. Research on association of calpain10 gene SNP-19 with polycystic ovary syndrome. Chin. J. Obstet. Gynecol. 2007, 42:628-630.
31. Unsal T., et al. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2009, 26:205-216.
32. Urbanek M. The genetics of the polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:103-111.
33. Vollmert C., et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E836-E844.
34. Yilmaz M., et al. Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome. J. Endocrinol. Invest. 2009, 32:13-17.
35. Zintzaras E., Ioannidis J.P. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005, 21:3672-3673.